329927-89-1Relevant academic research and scientific papers
Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
-
, (2008/06/13)
Pharmaceutical preparation comprising at least one phosphodiesterase V inhibitor and at least one nitrate for the preparation of a medicament for the treatment of angina, high blood pressure, pulmonary hypertension, congestive heart failure (CHF), chronic
Thienopyrimidines as phosphodiesterase inhibitors
-
Page/Page column 8, (2008/06/13)
Thienopyrimidines of the formula I and their physiologically acceptable salts, in which R1, R2and X have the meanings indicated in claim 1, exhibit phosphodiesterase V inhibition and can be employed for the treatment of disorders of
Use of pde v inhibitors
-
, (2008/06/13)
The invention relates to the use of a highly penis-specific PDE V inhibitor, or a physiologically acceptable salt or solvate thereof, for the production of a medicament for the treatment of erectile dysfunction in males, without the previous circulatory s
Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
-
, (2008/06/13)
Thienopyrimidines of the formula I and their physiologically acceptable salts, in which R1, R2and X have the meanings given in claim1, inhibit phosphodiesterase V and can be employed for the treatment of illnesses of the cardiovascul
